Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2003-06-30
2010-12-14
Gupta, Anish (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S324000
Reexamination Certificate
active
07851440
ABSTRACT:
The present invention relates to a peptide for the specific recognition of lipid vectors. The peptide of the invention comprises the peptide sequence (I; SEQ ID NO: 15) below:(I)J1-J2-J3-J4-J5-J6-Z7-U8-J9-J10-U11-Arg-J13-J14-U15-Lys-Gly-X18-Gly-Thr-J21-Glu-J23-J24-U25-J26-J27-J28-U29-J30-J31-Arg-J33-J34-J35-J36-B37-J38-J39-U40-J41-J42-J43-U44-J45-J46-J47-J48-J49-Arg-J51-U52-J53-J54-Asp-U56-Lys-Ser-Z59-Leu-J61-J62-J63-J64-Z65-J66-J67-U68-J69-J70-J71-U72-J73-J74-J75in which the amino acids J are chosen, independently of one another, from essential amino acids, or derivatives thereof, such that at least 50% of them are polar residues chosen from Arg, Asn, Asp, Cys, Gln, Glu, Gly, His, Lys, Orn, Pro, Ser, Thr and Tyr; the amino acids U are chosen, independently of one another, from Ala, Cys, Gly, Ile, Leu, Met, Phe, Trp, Tyr and Val; the amino acid X18is chosen, independently of the other amino acids of the sequence, from Ala, Asn, Cys, Gln, Gly, His, Ile, Leu, Met, Phe, Ser, Thr, Trp, Tyr and Val; the amino acid B37is chosen, independently of the other amino acids of the sequence, from Arg, Ala, Cys, Gly, Ile, Leu, Met, Phe, Trp, Tyr and Val; the amino acid Z7is chosen, independently of the other amino acids of the sequence, from Asp and Gly; the amino acids Z59and Z65are chosen from Glu, Asp, Lys or Arg; and the superscripts of the residues J, Z, U, X and B represent the position of these amino acids in said sequence.
REFERENCES:
patent: 2002/0044941 (2002-04-01), Rosen et al.
patent: 293 567 (1988-12-01), None
patent: 92/19279 (1992-11-01), None
patent: 00/10673 (2000-03-01), None
patent: 00/20453 (2000-04-01), None
Pierre Montaville, et al., “A new consensus sequence for phosphatidylserine recognition by annexins”, The Journal of Biological Chemistry, vol. 277, No. 27, pp. 24684-24693 Jul. 5, 2002.
Carol L. Sable, et al., “Cloning and functional activity of a novel truncated formed of annexin IV in mouse macrophages”, Biochemical and Biophysical Research Communications, vol. 258, No. 1, pp. 162-167 1999.
Shuang Liu, et al., “99mTc labeling of highly potent small peptides”, Bioconjugate Chem., vol. 8, No. 5, pp. 621-636 1997.
Kanthi P. Pulukkody, et al., “Synthesis of charged and uncharged complexes of gadolinium and yttrium with cyclic polyazaphosphinic acid ligands for in vivo applications”, J. Chem. Soc. Perkin. Trans., vol. 2, pp. 605-620 1993.
Ochsenbein Francoise
Sanson Alain
Commissariat a l''Energie Atomique
Gupta Anish
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Universite Pierre et Marie Curie (Paris VI)
LandOfFree
Peptides with affinity for a phospholipid and uses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides with affinity for a phospholipid and uses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides with affinity for a phospholipid and uses will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4171572